Phosphoinositide 3-Kinase Inhibitors in Lymphoma

Current Opinion in Oncology - United States
doi 10.1097/cco.0000000000000113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Phosphoinositide 3-Kinase-Δ (PI3Kδ); Phosphoinositide 3-Kinase Catalytic Subunit Δ-Polypeptide (PI3KCD; P110δ)

Science-Business eXchange
2014English

Phosphoinositide 3-Kinase-Γ (PI3Kγ)

Science-Business eXchange
2011English

Phosphoinositide 3-Kinase-Β (PI3Kβ); PI3Kδ

Science-Business eXchange
2011English

Phosphoinositide 3-Kinase Δ (PI3Kδ) in Respiratory Disease

Biochemical Society Transactions
Biochemistry
2018English

Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2013English

3-Phosphoinositide–dependent Protein Kinase-1 (PDPK1)

Science-Business eXchange
2013English

Furan-2-Ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase G

English

Multiple Phosphoinositide 3-Kinase-Dependent Steps in Activation of Protein Kinase B

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2002English

Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma

iScience
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy